Clinical and morphological features of different types of Castleman’s disease
- Authors: Melikyan AL1, Egorova EK1, Kovrigina АМ1, Subortseva IN1, Gilyazitdinova EA1, Karagyulyan SR1, Silaev MA1, Gemdzhian EG1, Savchenko VG1
-
Affiliations:
- «Гематологический научный центр» Минздрава России
- Issue: Vol 87, No 7 (2015)
- Pages: 64-71
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31777
- ID: 31777
Cite item
Full Text
Abstract
About the authors
A L Melikyan
«Гематологический научный центр» Минздрава РоссииМосква, Россия
E K Egorova
«Гематологический научный центр» Минздрава РоссииМосква, Россия
А М Kovrigina
«Гематологический научный центр» Минздрава РоссииМосква, Россия
I N Subortseva
«Гематологический научный центр» Минздрава РоссииМосква, Россия
E A Gilyazitdinova
«Гематологический научный центр» Минздрава РоссииМосква, Россия
S R Karagyulyan
«Гематологический научный центр» Минздрава РоссииМосква, Россия
M A Silaev
«Гематологический научный центр» Минздрава РоссииМосква, Россия
E G Gemdzhian
«Гематологический научный центр» Минздрава РоссииМосква, Россия
V G Savchenko
«Гематологический научный центр» Минздрава РоссииМосква, Россия
References
- Castleman B, Thowne VW. Case records of the Massachusetts General Hospital Weekly Clinicopathological Exercises: Case 40011. New Engl J Med. 1954;250:26-30.
- Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9(4):822-830.
- Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29(3):670-683.
- Flendring JA. Benign giant lymphoma: Clinicopathologic correlation study, in Clark RL, Cumley RS. The Year book of cancer. Chicago: Year book; 1986:296.
- Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol. 1978;69(1):86-90.
- Martin JM, Bell B, Ruether BA. Giant lymph node hyperplasia (Castleman’s disease) of hyaline vascular type. Clinical heterogeneity with immunohistologic uniformity. Am J Clin Pathol. 1985;84(4):439-446.
- Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman’s disease: clinical findings and clinicopathologic correlation in 15 patients. J Clin Oncol. 1985;3(3):1202.
- Frizzera G. Castleman’s disease and related disorders. Semin DiagnPathol. 1988;5(4):346-364.
- Hanson CA, Frizzera G, Patton DF, Peretson BA, McClain KL, Gajl-Peczalska KJ, Kersey JH. Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman’s disease: association with Epstein Barr virus. Am J Pathol. 1988;131(1):84-91.
- Soulier J, Grollet L, Oksenhendler E, Miciea J-M, Cacoub P, Baruchel A, Brice P, Clauvel J-P, d’Agay M-F, Raphael M, Sigaux F. Molecular analysis of clonality in Castleman’s disease. Blood. 1995;86(3):1131-1138.
- Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Lee T, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease. Blood. 1989;74(4):1360-1367.
- Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266(5192): 865-1869.
- Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. Lytic growth of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med. 1996;2(3):342-346.
- El-Osta HE, Kurzrock R. Castleman’s disease: from basic mechanisms to molecular therapeutics. Oncologist. 2011;16(4):497-511.
- Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br JHaematol. 2005;129(1):3-17. Review.
- Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, Brennan MF. The management of unicentric and multicentric Castleman’s disease: a report of 16 cases and a review of the literature. Cancer. 1999;85(3):706-717.
- McClain KL, Natkunam Y, Swerdlow SH. Atypical cellular disorders. Hematology Am Soc Hematol Educ Program. 2004:283-296.
- Kim JE, Kim JC, Park IA, Kim WH, Seo JW, Jang JJ, Kim CW, Park SH, Lee HS, Chi JG, Kim YI, Ham EK. Clinicopathologic study of Castleman’s disease in Korea. J Korean Med Sci. 2000;15(4):393-398.
- Saeed-Abdul-Rahman I, Al-Amri AM. Castleman disease. Korean JHematol. 2012;47(3):163-177.
- Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv AnatPathol. 2009;16(4):236-246.
- Talat N, Schulte KM. Castleman’s disease: systematic analysis of 416 patients from the literature. Oncologist. 2011;16(9):1316-1324.
- Menke DM. Ly-1b cells and Castleman disease. Blood. 2000;96(4):1614-1616.
- Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95(4):1406-1412.
- Ioachim HL, Howard R. Ioachims lymph node pathology. Textbook and color atlas. Philadelphia: JB Lippinott Co; 2006: Chapter 43:246-253.
- Меликян А.Л., Капланская И.Б., Корнева Е.П., Франк Г.А. Болезнь Кастлемана. Терапевтический архив 2005;7:48-53.
- Меликян А.Л. Болезнь Кастлемана. Атлас. Опухоли лимфатической системы. Под ред. Воробьева А.И., Кременецкой А.М. М.; 2007:259-262.
![](/img/style/loading.gif)